142 related articles for article (PubMed ID: 16198839)
1. Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes.
Mallat Z; Steg PG; Benessiano J; Tanguy ML; Fox KA; Collet JP; Dabbous OH; Henry P; Carruthers KF; Dauphin A; Arguelles CS; Masliah J; Hugel B; Montalescot G; Freyssinet JM; Asselain B; Tedgui A
J Am Coll Cardiol; 2005 Oct; 46(7):1249-57. PubMed ID: 16198839
[TBL] [Abstract][Full Text] [Related]
2. CRP, interleukin-6, secretory phospholipase A2 group IIA, and intercellular adhesion molecule-1 during the early phase of acute coronary syndromes and long-term follow-up.
Hartford M; Wiklund O; Mattsson Hultén L; Perers E; Person A; Herlitz J; Hurt-Camejo E; Karlsson T; Caidahl K
Int J Cardiol; 2006 Mar; 108(1):55-62. PubMed ID: 16516698
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris.
Kugiyama K; Ota Y; Sugiyama S; Kawano H; Doi H; Soejima H; Miyamoto S; Ogawa H; Takazoe K; Yasue H
Am J Cardiol; 2000 Oct; 86(7):718-22. PubMed ID: 11018189
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.
de Lemos JA; Morrow DA; Bentley JH; Omland T; Sabatine MS; McCabe CH; Hall C; Cannon CP; Braunwald E
N Engl J Med; 2001 Oct; 345(14):1014-21. PubMed ID: 11586953
[TBL] [Abstract][Full Text] [Related]
5. Serum secretory phospholipase A2-IIa (sPLA2-IIA) levels in patients surviving acute myocardial infarction.
Xin H; Chen ZY; Lv XB; Liu S; Lian ZX; Cai SL
Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):999-1004. PubMed ID: 23661511
[TBL] [Abstract][Full Text] [Related]
6. Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study.
Mallat Z; Benessiano J; Simon T; Ederhy S; Sebella-Arguelles C; Cohen A; Huart V; Wareham NJ; Luben R; Khaw KT; Tedgui A; Boekholdt SM
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1177-83. PubMed ID: 17303774
[TBL] [Abstract][Full Text] [Related]
7. [Haemostatic and inflammation markers in acute coronary syndromes and its relationship with adverse cardiovascular events].
Díaz CJ; Núñez AC; Flores MI; Arcaute HD; Archondo T
Arch Cardiol Mex; 2006; 76(4):366-75. PubMed ID: 17315612
[TBL] [Abstract][Full Text] [Related]
8. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
[TBL] [Abstract][Full Text] [Related]
9. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
10. Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.
Nicholls SJ; Kastelein JJ; Schwartz GG; Bash D; Rosenson RS; Cavender MA; Brennan DM; Koenig W; Jukema JW; Nambi V; Wright RS; Menon V; Lincoff AM; Nissen SE;
JAMA; 2014 Jan; 311(3):252-62. PubMed ID: 24247616
[TBL] [Abstract][Full Text] [Related]
11. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
[TBL] [Abstract][Full Text] [Related]
12. Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy.
Cohen M; Stinnett SS; Weatherley BD; Gurfinkel EP; Fromell GJ; Goodman SG; Fox KA; Califf RM
Am Heart J; 2000 Jun; 139(6):962-70. PubMed ID: 10827375
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of a single measurement of troponin-I and C-reactive protein at admission in 1773 consecutive patients with acute coronary syndromes.
Oltrona L; Ottani F; Galvani M;
Am Heart J; 2004 Sep; 148(3):405-15. PubMed ID: 15389226
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome.
Kaski JC; Consuegra-Sanchez L; Fernandez-Berges DJ; Cruz-Fernandez JM; Garcia-Moll X; Marrugat J; Mostaza J; Toro-Cebada R; González-Juanatey JR; Guzmán-Martínez G;
Atherosclerosis; 2008 Nov; 201(1):176-83. PubMed ID: 18336825
[TBL] [Abstract][Full Text] [Related]
15. ST-segment deviation on the admission electrocardiogram, treatment strategy, and outcome in non-ST-elevation acute coronary syndromes A substudy of the Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) Trial.
Windhausen F; Hirsch A; Tijssen JG; Cornel JH; Verheugt FW; Klees MI; de Winter RJ;
J Electrocardiol; 2007; 40(5):408-15. PubMed ID: 17604045
[TBL] [Abstract][Full Text] [Related]
16. [Elevated serum secretory type II phospholipase A2 in patients with coronary heart disease].
Yu L; Jiang WB; Fu GS; Qin GM; Wang JH; Huang ZQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):812-5. PubMed ID: 17217690
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]).
Lim P; Moutereau S; Simon T; Gallet R; Probst V; Ferrieres J; Gueret P; Danchin N
Am J Cardiol; 2013 Jan; 111(1):31-7. PubMed ID: 23062316
[TBL] [Abstract][Full Text] [Related]
18. Increasing post-event plasma thrombomodulin level associates with worse outcome in survival of acute coronary syndrome.
Chan SH; Chen JH; Li YH; Lin LJ; Tsai LM
Int J Cardiol; 2006 Aug; 111(2):280-5. PubMed ID: 16307806
[TBL] [Abstract][Full Text] [Related]
19. Metabolic score--a simple risk marker in non-ST elevation acute coronary syndromes.
Raposo L; Ferreira J; Aguiar C; Gonçalves Pde A; Couto R; Seabra Gomes R
Rev Port Cardiol; 2006 Feb; 25(2):155-71. PubMed ID: 16673646
[TBL] [Abstract][Full Text] [Related]
20. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease).
White HD; Tonkin A; Simes J; Stewart R; Mann K; Thompson P; Colquhoun D; West M; Nestel P; Sullivan D; Keech AC; Hunt D; Blankenberg S;
J Am Coll Cardiol; 2014 Feb; 63(4):345-54. PubMed ID: 24140630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
